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Background {#cam41452-sec-0001}
==========

Mitochondria are complex and dynamic organelle [1](#cam41452-bib-0001){ref-type="ref"} containing 2--10 mitochondrial DNA (mtDNA) molecules [2](#cam41452-bib-0002){ref-type="ref"}, which explore a significant role in the function and longevity of the vast majority of eukaryotic cell and organisms [1](#cam41452-bib-0001){ref-type="ref"}. Human mitochondrial DNA is a circular double‐stranded DNA molecule of 16.6 kb, and encodes 33 genes responsible for its protein synthesis (22 tRNAs and 2 rRNAs) and the respiratory chain (13 polypeptides) [2](#cam41452-bib-0002){ref-type="ref"}, [3](#cam41452-bib-0003){ref-type="ref"}. Compared to nuclear genome, the lack of introns and protective histones makes mtDNA susceptible to damage from reactive oxygen species (ROS) and other damaging agents [4](#cam41452-bib-0004){ref-type="ref"}. Additionally, alterations of mtDNA via inactivating genetic mutations or depleting mtDNA copy number may induce the damage of mitochondrial respiration and contribute to multiple disease, such as encephalopathies, neuropathies, and cancers [5](#cam41452-bib-0005){ref-type="ref"}, [6](#cam41452-bib-0006){ref-type="ref"}, [7](#cam41452-bib-0007){ref-type="ref"}.

The mtDNA copy number varies greatly between different tissues [8](#cam41452-bib-0008){ref-type="ref"}, but remains relatively stable in normal cells [9](#cam41452-bib-0009){ref-type="ref"}. Researchers have demonstrated that abnormal mtDNA copy number is involved in the development of various cancers, such as lung cancer [10](#cam41452-bib-0010){ref-type="ref"}, papillary thyroid carcinomas [11](#cam41452-bib-0011){ref-type="ref"}, breast cancer [12](#cam41452-bib-0012){ref-type="ref"}, hepatic cell carcinomas [13](#cam41452-bib-0013){ref-type="ref"}, gastric cancers [14](#cam41452-bib-0014){ref-type="ref"}, and ovary cancer [15](#cam41452-bib-0015){ref-type="ref"}. Furthermore, epidemiological researches have explored the significance of the mtDNA copy number in PBLs, which can serve as a potential biomarker of cancer risk prediction. However, the results were inconclusive in different cancers. For example, higher mtDNA copy number was related to the elevated risk of renal cell carcinoma [16](#cam41452-bib-0016){ref-type="ref"}, but lower mtDNA copy number increased the risk of endometrial cancer and melanoma [17](#cam41452-bib-0017){ref-type="ref"}, [18](#cam41452-bib-0018){ref-type="ref"}.

Head and neck cancer mainly includes squamous cell carcinomas situating in oral cavity, oropharynx, hypopharynx, and larynx [19](#cam41452-bib-0019){ref-type="ref"}. It ranks sixth among all cancers and accounts for about 4% new cases and 5% deaths of all malignancies around the world [20](#cam41452-bib-0020){ref-type="ref"}. In China, the incidence of HNSCC is relatively low; however, the total number of cases is large because of its vast population. It was reported that there were about 74.5 thousand new cases and 36.6 thousand cases died of HNSCC in 2015 [21](#cam41452-bib-0021){ref-type="ref"}. Some reports and studies have focused on the role of mtDNA copy number in HNSCC development [22](#cam41452-bib-0022){ref-type="ref"}, [23](#cam41452-bib-0023){ref-type="ref"}, [24](#cam41452-bib-0024){ref-type="ref"}, [25](#cam41452-bib-0025){ref-type="ref"}, [26](#cam41452-bib-0026){ref-type="ref"}, [27](#cam41452-bib-0027){ref-type="ref"}; however, the sample sizes were relatively small (total number of cases and controls: 155--500) and their results were inconsistent [22](#cam41452-bib-0022){ref-type="ref"}, [23](#cam41452-bib-0023){ref-type="ref"}, [24](#cam41452-bib-0024){ref-type="ref"}, [25](#cam41452-bib-0025){ref-type="ref"}, [26](#cam41452-bib-0026){ref-type="ref"}, [27](#cam41452-bib-0027){ref-type="ref"}. Thus, we examined the relationship between mtDNA copy number and HNSCC risk in a relatively larger case--control study (570 HNSCC cases and 597 controls) in China.

Methods {#cam41452-sec-0002}
=======

Study participants {#cam41452-sec-0003}
------------------

A total of 570 newly diagnosed HNSCC cases were recruited through Jiangsu Stomatological Hospital and the First Affiliated Hospital of Nanjing Medical University, since January 2009 to May 2013. All cases were first diagnosed with HNSCC cancer in the hospitals and did not receive any cancer‐related treatment (chemotherapy/radiotherapy) before this study. A total of 597 cancer‐free controls were randomly chosen from more than 30,000 individuals who participated in a screening program for noninfectious diseases in Jiangsu province, China. Cases and controls were frequency‐matched on age and sex. After signed the informed consent, all participants completed the standard questionnaire through the face‐to‐face interview. Data were collected on demographics including age and gender, and some exposure factors such as tobacco smoking and alcohol consumption. Individuals who had smoked an average of one or more cigarettes per day for at least 1 year were defined as smokers, and those who had more than one alcoholic drink per day were considered as drinkers. A fasting blood sample (\~5 mL) was collected in the morning when each patient was admitted to hospital and had not received any treatment. Additionally, the fasting blood sample was also taken from each control for DNA extraction. All subjects were genetically unrelated Han Chinese. The study was approved by the Ethics Committee of Nanjing Medical University.

Measurement of mtDNA copy number {#cam41452-sec-0004}
--------------------------------

DNA was extracted from PBLs by traditional phenol--chloroform method. A quantitative reverse transcription PCR‐based method was used to determine the relative mtDNA copy number in PBLs according to procedures described previously [28](#cam41452-bib-0028){ref-type="ref"}, [29](#cam41452-bib-0029){ref-type="ref"}. Briefly, two primer sets were respectively designed to amplify the ND1 gene in mtDNA and the nuclear gene HGB to measure the mtDNA copy number as described by Liu et al. [28](#cam41452-bib-0028){ref-type="ref"}. The mitochondrial gene quantitative PCR (qPCR) primers were ND1‐F (5′‐CCCTAAAACCCGCCACATCT‐3′) and ND1‐R (5′‐GAGCGATGGTGAGAGCTAAGGT‐3′), while the nuclear gene (HGB) qPCR primers were HGB‐1 (5′‐GAAGAGCCAAGGACAGGTAC‐3′) and HGB‐2 (5′‐CAACTTCATCCACGTTCACC‐3′). The final primer concentration used for the real‐time PCR assay was 10 μmol/μL. The mtDNA copy number was expressed as the ratio of *ND1* and *HGB* threshold cycle numbers in individual samples, and it was calculated in accordance with the formula [28](#cam41452-bib-0028){ref-type="ref"}: mtDNA copy number = 2 × 2^(Ct(HGB)‐Ct(ND1))^. A genomic DNA pool from five healthy donors was serially diluted 1:2 to generate a standard curve ranging from 0.625 to 20 ng of DNA for which the *R* ^2^ for each standard curve was 0.99 or greater. Samples that fell outside the range defined by the standard curves were rerun at a different concentration to ensure that they were amplified within the linear range. The PCR mixture in each well included 1× SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA), ND1‐R (or HGB‐1) primer, ND1‐F (or HGB‐2) primer and genomic DNA. All samples were evaluated by ABI PRISM 7900HT Sequence Detection System in duplicate on a 384‐well plate. Especially, the PCRs for mtDNA and HGB of the same samples were carried out on separate 384‐well plates in the same well positions. Quality control samples were run with the case--control sets in each batch. Mean values within and between batch coefficients of variation based on the quality control samples were 1.86% and 6.16%, respectively. The coefficient of variation is an effect size measure, which is defined as the ratio of the standard deviation to the mean. All laboratory personnel were blinded to the case or control status.

Statistical analysis {#cam41452-sec-0005}
--------------------

Pearson\'s chi‐square test was used to evaluate the differences in demographics (age, sex) and risk factors (tobacco smoking, alcohol consumption) between cases and controls. Additionally, rank‐sum test was conducted to detect mtDNA copy number differences in PBLs between cases and controls, and between subgroups with different age, sex, smoking, and drinking. We categorized mtDNA copy number into three or four groups based on its tertile or quartile distributions in controls, respectively, aiming to detect the association between mtDNA copy number and the risk of HNSCC. Unconditional logistic regression was used to compute ORs and 95% CI in each mtDNA copy number quartile, adjusting for age, sex, smoking and drinking status. Restricted cubic spline analysis in logistic regression model was used to derive the shape of relationship between mtDNA copy number and HNSCC risk. All tests for *P* values were two‐sided, with *P *\<* *0.05 considered statistically significant. Stata/SE 11.0 (StataCorp LP, Lakeway Drive College Station, Texas, USA) and SAS version 9.1.3 (SAS Institute, NC, USA) were used for statistical analyses.

Result {#cam41452-sec-0006}
======

Primary information {#cam41452-sec-0007}
-------------------

Table [1](#cam41452-tbl-0001){ref-type="table-wrap"} shows the characteristics of subjects in our study. A total of 570 HNSCC cases and 597 controls were included in the analysis. Differences of age and sex were nonsignificant (*P *\>* *0.05), and the mean age and standard deviation (SD) for cases and controls were 61.07 ± 10.88 and 59.62 ± 9.35, respectively. However, HNSCC cases (44.21%) had higher proportion of drinkers than that in the cancer‐free controls (32.16%) (*P *\<* *0.05), while that of smokers between two groups were similar (*P *\>* *0.05). More than 80% of cases were those with cancer of oral cavity, nearly 20% with larynx and around 2% with oropharynx and others.

###### 

Distributions of characteristics in HNSCC cases and controls

  Variables                                       Cases *N* (%)   Controls *N* (%)   *P* [a](#cam41452-note-0004){ref-type="fn"}
  ----------------------------------------------- --------------- ------------------ ---------------------------------------------
  All subjects                                    570 (100.00)    597 (100.00)       
  Age                                                                                
   \<60                                           277 (48.60)     285 (47.74)        0.769
   ≥60                                            293 (51.40)     312 (52.26)        
  Gender                                                                             
   Females                                        213 (37.37)     223 (37.35)        0.996
   Males                                          357 (62.63)     374 (62.65)        
  Smoking status                                                                     
   Never                                          312 (54.74)     344 (57.62)        0.321
   Ever                                           258 (45.26)     253 (42.38)        
  Drinking status                                                                    
   Never                                          318 (55.79)     405 (67.84)        **\<0.001**
   Ever                                           252 (44.21)     192 (32.16)        
  Tumor sites                                                                        
   Oral cavity                                    458 (80.53)                        
   Oropharynx                                     9 (1.58)                           
   Larynx                                         100 (17.54)                        
   Other[b](#cam41452-note-0005){ref-type="fn"}   3 (0.53)                           

HNSCC, head and neck squamous cell carcinoma.

Two‐sided chi‐square test.

Including nasal sinuses, parotid, and salivary gland.

P value in bold is statistically significant.

John Wiley & Sons, Ltd

We also evaluated mtDNA copy number among cancer‐free controls with various characteristics, and no apparent difference was found between subgroups by age, gender, tobacco smoking or alcohol drinking (Table [2](#cam41452-tbl-0002){ref-type="table-wrap"}).

###### 

Distributions of mtDNA copy number among cancer‐free controls

  Selected variables   *N*   mtDNA copy number median (quartile)   *P* [a](#cam41452-note-0006){ref-type="fn"}
  -------------------- ----- ------------------------------------- ---------------------------------------------
  Overall              597   3.50 (1.93--11.22)                    
  Age                                                              
   \<60                285   3.33 (1.94--9.23)                     0.273
   ≥60                 312   3.90 (1.89--12.84)                    
  Gender                                                           
   Male                374   3.46 (1.83--11.21)                    0.48
   Female              223   3.59 (2.06--11.85)                    
  Smoking status                                                   
   Never               344   3.51 (2.00--11.83)                    0.627
   Ever                253   3.47 (1.76--10.88)                    
  Drinking status                                                  
   Never               405   3.59 (1.90--12.09)                    0.684
   Ever                192   3.43 (2.00--9.44)                     

Derived from rank‐sum test for mtDNA copy number between subgroups divided by characteristics.
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The association of mtDNA copy number with HNSCC risk {#cam41452-sec-0008}
----------------------------------------------------

The mtDNA copy number significantly elevated in HNSCC cases than that in controls (median: 4.33 vs. 3.50, *P *=* *0.016). Then, we categorized participants into four groups based on quartile distribution of mtDNA copy number in controls and evaluated the relationship between mtDNA copy number and HNSCC risk. Compared with the subjects in the second quartile group, a significantly increased risk of HNSCC was detected in both groups with the lowest quartile and highest quartile groups of relative mtDNA copy number \[adjusted OR (95% CIs), 1.95 (1.37--2.76), 2.16 (1.53--3.04)\] (Table [3](#cam41452-tbl-0003){ref-type="table-wrap"}). We also categorized participants into three groups based on tertile distribution of mtDNA copy number in controls and the result confirmed the finding from quartile groups (Table [3](#cam41452-tbl-0003){ref-type="table-wrap"}). Further, we also found a significant U‐shaped association using the restricted cubic spline analysis (Fig. [1](#cam41452-fig-0001){ref-type="fig"}).

###### 

Association between mtDNA copy number (mtDNAcn) and HNSCC risk

  Groups of mtDNA copy number by control category   Controls *N* (%)   Cases                                                         
  ------------------------------------------------- ------------------ ------------- ----------------------- ----------------------- -------------
  Quartile                                          \<1.93             150 (25.13)   165 (28.95)             **1.95 (1.37--2.76)**   **\<0.001**
  1.93--3.50                                        149 (24.96)        89 (15.61)    1.00 (reference)        ---                     
  3.50--11.22                                       149 (24.96)        119 (20.88)   1.34 (0.93--1.92)       0.116                   
  \>11.22                                           149 (24.96)        197 (34.56)   **2.16 (1.53--3.04)**   **\<0.001**             
  Tertile                                           \<2.38             199 (33.33)   195 (34.21)             **1.62 (1.19--2.19)**   **0.002**
  2.38--6.49                                        199 (33.33)        128 (22.46)   1.00 (reference)        ---                     
  ≥6.49                                             199 (33.33)        247 (43.33)   **1.90 (1.41--2.55)**   **\<0.001**             

Derived from logistic regression with an adjustment for age at blood collection, sex, smoking and drinking status.

P value in bold is statistically significant.

John Wiley & Sons, Ltd

![Association between mtDNA copy number and HNSCC risk based on restricted cubic spline function in the logistic regression model.](CAM4-7-2776-g001){#cam41452-fig-0001}

When the above association was stratified by age, gender, tobacco smoking and alcohol consumption, the U‐shaped association still existed in both young and old subjects, women and men, nonsmokers and smokers, nondrinkers and drinkers and no significant heterogeneity was observed in every two strata (*P *\>* *0.05). (Table [4](#cam41452-tbl-0004){ref-type="table-wrap"}).

###### 

Stratified analyses of association between mtDNA copy number and HNSCC

  Variables                                                     mtDNA copy number in quartile                                                     
  ------------------------------------------------------------- ------------------------------- --------- ------------------- ------------------- ---------
  Age                                                                                                                                             
   \<60                                                         Cases/Controls                  82/69     46/81               62/72               87/63
  Adjusted OR (95% CI)[a](#cam41452-note-0008){ref-type="fn"}   2.17 (1.33--3.54)               1.00      1.51 (0.91--2.50)   2.36 (1.44--3.87)   
   ≥60                                                          Cases/Controls                  83/80     43/69               57/77               110/86
  Adjusted OR (95% CI)[a](#cam41452-note-0008){ref-type="fn"}   1.78 (1.08--2.92)               1.00      1.20 (0.72--2.02)   2.09 (1.29--3.38)   
  Gender                                                                                                                                          
   Male                                                         Cases/Controls                  110/101   57/91               75/89               115/93
  Adjusted OR (95% CI)                                          1.88 (1.22--2.92)               1.00      1.36 (0.86--2.15)   1.99 (1.28--3.09)   
   Female                                                       Cases/Controls                  55/48     32/59               44/60               82/56
  Adjusted OR (95% CI)[a](#cam41452-note-0008){ref-type="fn"}   2.10 (1.17--3.78)               1.00      1.25 (0.69--2.26)   2.54 (1.46--4.44)   
  Smoking                                                                                                                                         
   No                                                           Cases/Controls                  93/78     50/93               67/85               102/88
  Adjusted OR (95% CI)[a](#cam41452-note-0008){ref-type="fn"}   2.16 (1.36--3.41)               1.00      1.46 (0.91--2.34)   2.08 (1.33--3.27)   
   Yes                                                          Cases/Controls                  72/71     39/57               52/64               95/61
  Adjusted OR (95% CI)[a](#cam41452-note-0008){ref-type="fn"}   1.69 (0.97--2.95)               1.00      1.14 (0.64--2.03)   2.36 (1.36--4.09)   
  Drinking                                                                                                                                        
   No                                                           Cases/Controls                  100/103   55/94               63/102              100/106
  Adjusted OR (95% CI)[a](#cam41452-note-0008){ref-type="fn"}   1.73 (1.11--2.68)               1.00      1.06 (0.67--1.69)   1.58 (1.02--2.45)   
   Yes                                                          Cases/Controls                  65/46     34/56               56/47               97/43
  Adjusted OR (95% CI)[a](#cam41452-note-0008){ref-type="fn"}   2.27 (1.27--4.05)               1.00      1.97 (1.10--3.54)   3.60 (2.05--6.34)   
  Oral cancer                                                                                                                                     
   No                                                           Cases/Controls                  39/149    18/150              29/149              26/149
  Adjusted OR (95% CI)[a](#cam41452-note-0008){ref-type="fn"}   2.17 (1.16--4.06)               1.00      1.70 (0.89--3.27)   1.46 (0.75--2.83)   
   Yes                                                          Cases/Controls                  126/149   71/150              90/149              171/149
  Adjusted OR (95% CI)[a](#cam41452-note-0008){ref-type="fn"}   1.91 (1.31--2.78)               1.00      1.27 (0.86--1.88)   2.39 (1.66--3.44)   

Derived from logistic regression with an adjustment for age at blood collection, sex, smoking and drinking status.

John Wiley & Sons, Ltd

Discussion {#cam41452-sec-0009}
==========

In the present study, we conducted a case--control study to evaluate the relationship between mtDNA copy number and HNSCC risk and found that both extremely low and high mtDNA copy number had significant associations with the increased risk of HNSCC. These findings suggested that there was a U‐shaped association between mtDNA copy number and HNSCC risk, providing a novel perspective for understanding the significance of mtDNA in the etiology of HNSCC.

Mitochondria play critical roles in the maintenance of functionally competent organelles, and dysfunction of mitochondrial has been involved in various human pathologies including human cancers [6](#cam41452-bib-0006){ref-type="ref"}, [30](#cam41452-bib-0030){ref-type="ref"}. Abnormal mtDNA copy number may confer cancer development depending on a variety of mechanisms, including increased production of reactive oxygen species, decreased oxidative phosphorylation, increased expression of prosurvival proteins, and resistance to apoptosis [29](#cam41452-bib-0029){ref-type="ref"}, [31](#cam41452-bib-0031){ref-type="ref"}, [32](#cam41452-bib-0032){ref-type="ref"}, [33](#cam41452-bib-0033){ref-type="ref"}, [34](#cam41452-bib-0034){ref-type="ref"}, [35](#cam41452-bib-0035){ref-type="ref"}, [36](#cam41452-bib-0036){ref-type="ref"}, [37](#cam41452-bib-0037){ref-type="ref"}. For example, the lack of mtDNA altered gene expression in mitochondrial and caused an enhanced production of reactive oxygen species and deficiency in oxidative phosphorylation, inducing disrupted function of cells [38](#cam41452-bib-0038){ref-type="ref"}. Furthermore, multiple epidemiologic studies explored its significance as a marker in PBLs for tumor risk and found low mtDNA copy number would increase the risk of several cancers, such as breast tumors [12](#cam41452-bib-0012){ref-type="ref"}, [31](#cam41452-bib-0031){ref-type="ref"}, hepatic cell carcinomas [13](#cam41452-bib-0013){ref-type="ref"} and esophageal adenocarcinoma [39](#cam41452-bib-0039){ref-type="ref"}. However, some other studies indicated inverse relation between mtDNA copy number and risk of some special carcinomas including renal cell carcinoma [16](#cam41452-bib-0016){ref-type="ref"}, lung cancer [10](#cam41452-bib-0010){ref-type="ref"}, [40](#cam41452-bib-0040){ref-type="ref"} and papillary thyroid carcinoma [11](#cam41452-bib-0011){ref-type="ref"}. The biologic mechanism for high mtDNA copy number and the increased risk of cancer is still not fully understood. We speculated that increased mtDNA copy number in PBLs may be markers of elevated oxidative stress and ROS‐mediated DNA damage, and thus, higher mtDNA copy number may compensate for mtDNA damage/dysfunction [34](#cam41452-bib-0034){ref-type="ref"}, [35](#cam41452-bib-0035){ref-type="ref"}, [37](#cam41452-bib-0037){ref-type="ref"}. In the meantime, ROS produced by increased mitochondria may lead to more oxidative damage to some intracellular constituents, and then contribute to the initiation and promotion of carcinogenesis [41](#cam41452-bib-0041){ref-type="ref"}.

So far, six studies have discussed the association between mtDNA copy number and head and neck cancer (HNC) risk [22](#cam41452-bib-0022){ref-type="ref"}, [23](#cam41452-bib-0023){ref-type="ref"}, [24](#cam41452-bib-0024){ref-type="ref"}, [25](#cam41452-bib-0025){ref-type="ref"}, [26](#cam41452-bib-0026){ref-type="ref"}, [42](#cam41452-bib-0042){ref-type="ref"}, but results were inconsistent. For example, Lin et al. reported that the mtDNA copy number was significantly higher in HNC patients [22](#cam41452-bib-0022){ref-type="ref"}; however, the study by Takeda et al. reported that mtDNA copy number was decreased in tumor compared to that in normal tissue [26](#cam41452-bib-0026){ref-type="ref"}. Interestingly, we first found a U‐shaped relationship between mtDNA copy number and HNSCC risk, which was similarly reported by a nested case--control study that showed the lowest and highest quartile of mtDNA copy number were significantly associated with the increased risk of colorectal cancer [34](#cam41452-bib-0034){ref-type="ref"}. Thus, real associations between mtDNA copy number and risk of some cancers might be not a simple linear relationship. Previous studies on HNSCC failed to found such association, possibly because of relatively small sample size or lack of more detailed analysis. Actually, the U‐shaped association found in our study was biologically possible. Both extremely low and high copy number of mtDNA may lead to cell dysfunction and abnormal cell microenvironment, and finally result in the initiation and promotion of cancer [28](#cam41452-bib-0028){ref-type="ref"}, [29](#cam41452-bib-0029){ref-type="ref"}, [31](#cam41452-bib-0031){ref-type="ref"}, [32](#cam41452-bib-0032){ref-type="ref"}, [34](#cam41452-bib-0034){ref-type="ref"}, [35](#cam41452-bib-0035){ref-type="ref"}, [37](#cam41452-bib-0037){ref-type="ref"}, [43](#cam41452-bib-0043){ref-type="ref"}. Further studies with larger sample size and more rigorous design are warranted to confirm these finding.

Some limitations in the present study need to be pointed out. First of all, the statistical power may be limited because of a relatively modest sample size in this study, especially for stratification analysis. Secondly, this study was a case--control design, and we could not completely rule out the possibility of "reverse causal association." However, we have only included newly diagnosed and previously untreated patients to reduce the influence of disease status and treatment on mtDNA copy number. Thirdly, the mtDNA copy was measured in PBLs, but not in target tissues. Thus, it is unclear whether this change is really related to the etiology of head and neck cancer. Fourthly, mtDNA copy number was examined only once and repeated measurements over time were unavailable. Finally, this study was only conducted in Chinese Han population, so the external validity of conclusions might be limited.

In summary, this is the first study to show that both extremely high and low mtDNA copy numbers were related to HNSCC risk. The findings provided valuable clues for better understanding the role of mtDNA copy number in the development of HNSCC. However, prospective designed studies with a sufficient sample size are needed to verify our findings.
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